Ansun Revenue and Competitors
Estimated Revenue & Valuation
- Ansun's estimated annual revenue is currently $8.5M per year.
- Ansun's estimated revenue per employee is $155,000
Employee Data
- Ansun has 55 Employees.
Ansun's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO & Chairperson | Reveal Email/Phone |
2 | CEO & Chairperson | Reveal Email/Phone |
3 | SVP, Clinical Development & Operation | Reveal Email/Phone |
4 | VP Clinical Development | Reveal Email/Phone |
5 | VP Clinical Development | Reveal Email/Phone |
6 | VP CMC | Reveal Email/Phone |
7 | Senior Director | Reveal Email/Phone |
8 | Sr. Director, R&D | Reveal Email/Phone |
9 | Director | Reveal Email/Phone |
10 | Director Quality | Reveal Email/Phone |
Ansun Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Ansun?
Ansun BioPharma is a clinical stage biopharmaceutical company focused on the development of unique host-directed anti-viral therapies for respiratory viruses. Ansun BioPharma has two products in late stage clinical development. Fludase is a first-in-class broad-spectrum investigational therapeutic agent to treat all forms of influenza, including pandemic variants and drug-resistant variants that cannot be treated by any currently approved flu therapies, including H1N1, H5N1 and H7N9. Paradase is an investigational nebulized drug which is designed to target the receptor for parainfluenza viruses and is being evaluated in a Phase 2 trial for the treatment of lower tract parainfluenza infection in immunocompromised patients.
keywords:N/AN/A
Total Funding
55
Number of Employees
$8.5M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ansun News
... Zhaoqing City Dingkang Pharmaceutical, Ansun Bioengineering, Shanghai Join-Ray Biotechnology, MH2 Biochemical, Premium Ingredient.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $12.4M | 55 | 41% | N/A |
#2 | $13.4M | 55 | 4% | N/A |
#3 | $7.2M | 55 | N/A | N/A |
#4 | $7.2M | 55 | N/A | N/A |
#5 | $6.9M | 55 | -10% | $2M |